AstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emergency-Use Application

AstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emergency-Use Application

The British drugmaker could skip asking the FDA for emergency-use authorization for its Covid-19 vaccine—and instead pursue the more time-intensive application for a full-fledged license to sell the shot.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting